Is IMVIQ or VICI a better dividend investment in 2026?

IMVIQ currently yields 20000000.00% with a 5% 5-year dividend growth rate. VICI yields 6.52% with 8.1% growth. The better choice depends on your goal: IMVIQ offers higher current income.

What is the dividend yield difference between IMVIQ and VICI?

IMVIQ has a forward dividend yield of 20000000.00% ($2.00/share annually). VICI yields 6.52% ($1.78/share annually). The yield gap is 19999993.48 percentage points.

Home › Compare › IMVIQ vs VICI

IMVIQ vs VICI: Dividend Comparison 2026

IMVIQ yields 20000000.00% · VICI yields 6.52%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMVIQ wins by $4.875981653489057e+49M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMVIQ

● Live price

20000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.875981653489057e+49M

Annual income

$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00

Full IMVIQ calculator →

VICI

VICI Properties Inc.

● Live price

6.52%

Share price

$27.32

Annual div

$1.78

5Y div CAGR

44.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$966.2K

Annual income

$607,376.13

Full VICI calculator →

Portfolio growth — IMVIQ vs VICI

📍 IMVIQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMVIQ	VICI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMVIQ + VICI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMVIQ pays

VICI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMVIQ

Annual income on $10K today (after 15% tax)

$1,700,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

VICI

Annual income on $10K today (after 15% tax)

$554.58/yr

After 10yr DRIP, annual income (after tax)

$516,269.71/yr

At 15% tax rate, IMVIQ beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMVIQ + VICI for your $10,000?

IMVIQ: 50%VICI: 50%

100% VICI50/50100% IMVIQ

Portfolio after 10yr

$2.4379908267445285e+49M

Annual income

$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

IMVIQ

No analyst data

Altman Z

-12.0

Piotroski

1/9

VICI

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$31.60

+15.7% upside vs current

Range: $30.00 — $33.00

Altman Z

1.4

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMVIQ buys

VICI buys

No recent congressional trades found for IMVIQ or VICI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMVIQVICI

Forward yield	20000000.00% ✓	6.52%
Annual dividend / share	$2.00 ✓	$1.78
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	44.3% ✓
Portfolio after 10y	$4.875981653489057e+49M	$966.2K ✓
Annual income after 10y	$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$607,376.13
Total dividends collected	$4.875978515990276e+49M	$926.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: IMVIQ vs VICI ($10,000, DRIP)

Year	IMVIQ Portfolio	IMVIQ Income/yr	VICI Portfolio	VICI Income/yr	Gap
1← crossover	$2,000,010,700	$2,000,000,000.00	$11,361	$941.49	+$2000.00M → IMVIQ
2	$373,835,915,712,384	$373,833,775,700,934.50	$13,320	$1,481.32	+$373835915.70M → IMVIQ
3	$65,304,953,364,964,970,000	$65,304,553,360,535,160,000.00	$16,284	$2,405.01	+$65304953364964.95M → IMVIQ
4	$10,661,728,832,755,500,000,000,000	$10,661,658,956,455,399,000,000,000.00	$21,040	$4,071.78	+$10661728832755499008.00M → IMVIQ
5	$1,626,767,783,781,495,000,000,000,000,000	$1,626,756,375,731,643,800,000,000,000,000.00	$29,209	$7,285.49	+$1.626767783781495e+24M → IMVIQ
6	$231,974,330,054,625,100,000,000,000,000,000,000	$231,972,589,413,096,470,000,000,000,000,000,000.00	$44,443	$14,006.51	+$2.319743300546251e+29M → IMVIQ
7	$30,915,106,403,922,057,000,000,000,000,000,000,000,000	$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00	$75,822	$29,512.55	+$3.0915106403922057e+34M → IMVIQ
8	$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000	$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00	$148,733	$69,726.75	+$3.8505079858392777e+39M → IMVIQ
9	$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000	$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00	$344,394	$189,413.75	+$4.4821026103531426e+44M → IMVIQ
10	$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000	$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$966,234	$607,376.13	+$4.875981653489057e+49M → IMVIQ

IMVIQ vs VICI: Complete Analysis 2026

IMVIQ — Stock

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Full IMVIQ Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →

📬

Get this IMVIQ vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMVIQ vs SCHD IMVIQ vs JEPI IMVIQ vs O IMVIQ vs KO IMVIQ vs MAIN IMVIQ vs NNN IMVIQ vs EPRT IMVIQ vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.